Avanos Medical, Inc.
Avanos Medical, Inc., headquartered in the United States, is a prominent player in the medical device industry, specialising in innovative solutions for pain management and surgical care. Founded in 2014, the company has rapidly established itself as a leader in its field, focusing on advanced technologies that enhance patient outcomes and streamline healthcare processes. With a diverse portfolio that includes products for pain management, wound care, and respiratory health, Avanos Medical distinguishes itself through its commitment to quality and innovation. The company operates in key regions across North America and Europe, ensuring a broad reach in delivering its unique offerings. Notable achievements include significant advancements in regional anaesthesia and the development of proprietary devices that improve procedural efficiency. Avanos Medical continues to solidify its market position by prioritising patient-centric solutions and fostering strong partnerships within the healthcare community.
DitchCarbon Score
How does Avanos Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Avanos Medical, Inc.'s score of 22 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Avanos Medical, Inc.'s reported carbon emissions
In 2021, Avanos Medical, Inc. reported total carbon emissions of approximately 11,695,770 kg CO2e. This figure includes 229,240 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and a significant 11,466,530 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Currently, there are no disclosed reduction targets or climate pledges from Avanos Medical, indicating a potential area for future commitment in addressing climate change. The absence of Scope 3 emissions data suggests that the company may not yet be fully accounting for its entire carbon footprint, which typically includes emissions from the supply chain and product use. As a company headquartered in the US, Avanos Medical operates within an industry increasingly focused on sustainability and climate responsibility. The reported emissions data highlights the need for strategic initiatives to reduce their carbon impact and align with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | |
|---|---|
| Scope 1 | 229,240 |
| Scope 2 | 11,466,530 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Avanos Medical, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
